Work with thought leaders and academic experts in Genetics (clinical)

Companies can greatly benefit from working with experts in the field of Genetics (clinical). These professionals possess in-depth knowledge and skills that can be applied to various industries. By collaborating with them, companies can gain insights into genetic diseases, develop personalized medicine, improve drug discovery and development, enhance agricultural practices, and advance biotechnology. Genetics (clinical) experts can also help companies navigate ethical and legal considerations related to genetic research and ensure compliance with regulations. With their expertise, companies can drive innovation, solve complex challenges, and make a positive impact on human health and well-being.

Researchers on NotedSource with backgrounds in Genetics (clinical) include Ping Luo, Elvira Forte, Jeffrey Townsend, Katie Barr, Edoardo Airoldi, Dr. Justin Whalley, Ph.D, Luke Connelly, Marie Mooney, PhD, Mohsen Fathzadeh, K. Suzanne Scherf, Balamurugan Tangiisuran, Murli Manohar, and Shreeharsha Tarikere.

Ping Luo

Toronto, Ontario, Canada
8 Years Experience
Assistant Professor at Algoma University
Education

University of Saskatchewan

Ph.D., Biomedical Engineering / September, 2019

Saskatoon, Saskatchewan, Canada

Beijing Institute of Technology

M.Eng., Biomedical Engineering / June, 2015

Beijing

Hunan University

B.Eng., Computer Science / June, 2010

Changsha
Experience

Princess Margaret Cancer Centre

Postdoctoral Researcher / November, 2019 — Present

I work in Dr. Trevor Pugh's lab and design cancer diagnosis and treatment strategies by analyze cell-free DNA and single cell sequencing data

Princess Margaret Cancer Centre

Bioinformatics Specialist / September, 2023 — Present

I work in Dr. Tak Mak's lab and study tumor immunology using single cell and TCR sequencing data.

Research Expertise (22)
single-cell genomics
deep learning
complex network analysis
Genetics (clinical)
Genetics
And 17 more
About
8 years of science and engineering experience integrating multi-omics data to identify biomarkers for cancer studies. Seeking to apply data analytics expertise to develop new diagnosis and treatment strategies.

See Full Profile

Elvira Forte

New York, New York, United States of America
15 Years Experience
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education

Sapienza University of Rome

PhD, Pasteurian Sciences / January, 2011

Rome

Sapienza University of Rome

Master, Medical, Molecular and Cellular Biotechnology / October, 2006

Rome

Sapienza University of Rome

Bachelor, Biotechnology / October, 2004

Rome
Experience

Springer Nature

Associate/Senior Editor / June, 2021 — February, 2024

Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.

Research Fellow/Associate Research Scientist / January, 2017 — June, 2021

• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.

Post-doctoral fellow/ Co-joint lecturer / May, 2013 — November, 2016

Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales

Scientific Editor / March, 2024 — Present

Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.

Research Expertise (27)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 22 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.

See Full Profile

Jeffrey Townsend

New Haven, CT, Connecticut, United States of America
29 Years Experience
Professor of Biostatistics and Ecology & Evolutionary Biology
Education

Harvard University

Ph.D., Organismic and Evolutionary Biology / May, 2002

Cambridge, Massachusetts, United States of America

Brown University

Sc.B., Biology / May, 1994

Providence, Rhode Island, United States of America
Experience

Yale University

Professor / July, 2018 — Present

Elihu Professor of Biostatistics / July, 2018 — Present

Elihu Associate Professor of Biostatistics / July, 2017 — June, 2018

Associate Professor / July, 2013 — June, 2018

Associate Professor / July, 2013 — June, 2017

Assistant Professor / July, 2006 — June, 2013

University of Connecticut

Assistant Professor / August, 2004 — May, 2006

St. Ann's School

Teacher / September, 1994 — June, 1997

Research Expertise (53)
Evolutionary Genomics
Microbiology
Infectious Diseases
Genetics
Cell Biology
And 48 more
About
Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.

See Full Profile

Katie Barr

Warrington
8 Years Experience
Bioinformatician and developer with strong academic and commercial experience
Education

University of Leeds

Ph.D, Quantum Information / December, 2013

Leeds

University of Manchester

MSc, Mathematical logic and the theory of computation / December, 2009

Manchester

University of Bristol

BSc, Physics and Philosophy with study in Continental Europe / July, 2008

Bristol
Experience

Earlham Institute

Scientific programmer / November, 2015 — July, 2018

Genome assembly algorithm development

University of Manchester

Post doc bioinformatician in Nanomedicine group / June, 2019 — October, 2020

Wise range of bioinformatics tasks, mostly in RNASeq and Proteomics

Kromek

Associate Principal Scientist- Bioinformatics / November, 2020 — Present

Environmental metagenomics pipeline development for pathogen detection

Research Expertise (12)
Computer Science Applications
Atomic and Molecular Physics, and Optics
Bioengineering
Pharmacology (medical)
Biochemistry (medical)
And 7 more
About
Katie Barr is a bioinformatician with a strong background in computer science. She received her Ph.D in Quantum Information from the University of Leeds in 2013. She also holds an MSc in Mathematical logic and the theory of computation from the University of Manchester, and a BSc in Physics and Philosophy with study in Continental Europe from the University of Bristol. Katie has extensive experience working in the fields of bioinformatics and software development. She has worked as a scientific programmer at the Earlham Institute, a postdoctoral bioinformatician in the Nanomedicine group at the University of Manchester, and is now an Associate Principal Scientist in Bioinformatics at Kromek. Katie is passionate about using her knowledge and skills to improve the lives of others and she is dedicated to the advancement of science and technology. She believes in the power of collaboration and works to create meaningful partnerships between industry and academia.

See Full Profile

Edoardo Airoldi

Professor of Statistics & Data Science Temple University & PI, Harvard University
Education

Università Bocconi

B.Sc., Institute for Quantitative Methods

Milano

Carnegie Mellon University

Ph.D., School of Computer Science

Pittsburgh, Pennsylvania, United States of America
Experience

Harvard University

Research Expertise (44)
Statistics
Causal Inference
Network Science
Cell Biology
Molecular Biology
And 39 more
About
Edoardo Airoldi is a Professor in the Department of Machine Learning at Temple University. He is also the Director of the Center for Machine Learning and Health. He is a world-renowned expert in the fields of machine learning and artificial intelligence, with a focus on applications to health. Airoldi is a member of the prestigious Association for the Advancement of Artificial Intelligence (AAAI) and the International Machine Learning Society (IMLS). He has published over 200 papers in leading journals and conferences, and his work has been covered by various media outlets including The New York Times, The Wall Street Journal, The Economist, and Wired.

See Full Profile

Dr. Justin Whalley, Ph.D

North Chicago, Illinois, United States of America
9 Years Experience
Assistant Professor of Bioinformatics, with experience in finding the quintessential features in large, multi-layered 'omic datasets.
Education

Université d'Évry Val-d'Essonne

Ph.D., Bioinformatics / May, 2015

Évry

University of Bristol

M.Sci., Mathematics / June, 2008

Bristol
Experience

University of Oxford

Senior Bioinformatician / 2017 — 2022

Rosalind Franklin University of Medicine and Science Chicago Medical School

Assistant Professor of Bioinformatics / 2023 — Present

CNAG

Postdoctoral Researcher / 2014 — 2017

Research Expertise (19)
Genomics
Bioinformatics
Immunity
Tensor decomposition
Cancer
And 14 more
About
Dr. Justin P. Whalley was educated in the UK (M.Sci. Mathematics, University of Bristol) and France (Ph.D. Bioinformatics, University of Évry). He moved to Spain to work as a postdoc at the National Center for Genomic Analysis (CNAG). During his time there, he ran the Quality Control working group for the Pan-Cancer Analysis of Whole Genomes project to assess the data coming in and reduce batch effects. This involved collaboration with researchers from the Broad Institute of MIT and Harvard, the German Cancer Research Center and the Wellcome Sanger Institute in the UK. He returned to the UK to work as a [Senior Bioinformatician at the University of Oxford](https://www.well.ox.ac.uk/people/jpw/). His time there coincided with the global pandemic and he was deeply involved in the COvid-19 Multi-omics Blood ATlas (COMBAT) consortium as the lead for the Integration (Tensor) working group. Dr. Whalley became a member of the [faculty of the Chicago Medical School at Rosalind Franklin University of Medicine and Science](https://www.rosalindfranklin.edu/academics/faculty/justin-p-whalley/) in January 2023.

See Full Profile

Luke Connelly

25 Years Experience
Professor of Health Economics, The University of Queensland, CBEH
Education

University of Queensland

PhD, School of Economics / June, 1999

Brisbane, Queensland, Australia

University of Queensland

Master of Economic Studies, School of Economics / December, 1993

Brisbane, Queensland, Australia

University of Queensland

Bachelor of Arts (Economics), School of Economics / November, 1991

Brisbane, Queensland, Australia
Experience

The University of Bologna

Professor

The University of Queensland

Professor of Health Economics / May, 2015 — Present

Professor of Health Economics and Associate Director / January, 2008 — August, 2015

Associate Professor and Associate Director / May, 2003 — December, 2007

Queensland University of Technology

Senior Lecturer in Economics / May, 2000 — April, 2003

Lecturer / January, 1998 — April, 2000

Research Expertise (43)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 38 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

See Full Profile

Marie Mooney, PhD

7 Years Experience
Assistant Professor, University of North Florida specializing in Genetics, Neuroscience, and Bioinformatics
Education

Duke University

Postdoctoral Associate/Scholar, School of medicine / June, 2020

Durham , North Carolina, United States of America

Michigan State University

Postdoctoral Fellow, Pediatrics and Human Development / October, 2017

Grand Rapids, Michigan, United States of America

Van Andel Research Institute

Cell and Molecular Genetics, PhD, Graduate School / March, 2016

Grand Rapids, Michigan, United States of America
Experience

University of North Florida

Assisstant Professor of Bioinformatics / August, 2021 — Present

Lurie Children's Hospital

Postdoctoral Associate / July, 2020 — June, 2021

Duke University

Postdoctoral Associate / February, 2018 — June, 2020

Research Expertise (18)
translational medicine
bioinformatics
neuro-oncology
oncology
neurodevelopmental disorders
And 13 more
About
Marie Mooney, PhD is an Assistant Professor of Bioinformatics at the University of North Florida. She holds a PhD in Cell and Molecular Genetics from the Van Andel Research Institute, a MS in Biomedical Engineering from the University of Cincinnati, and a BS in Bioinformatics, from Michigan Technological University. Prior to her current role, she served as a Senior Postdoctoral Associate at Lurie Children's Hospital, A T32 Postdoctoral Scholar In Applied Genomics and Precision Medicine at Duke University, a Research Associate at Michigan State University. Her research focuses on integrative and translational approaches to repurpose therapeutics for use in rare congenital disorders. Her laboratory uses zebrafish as a genetic model organism to generate and test bioinformatics-driven hypotheses.

See Full Profile

Mohsen Fathzadeh

Research Scientist, Genomics, Stanford University
Education

Tehran University of Medical Sciences

Medical Genetics / 2015

Tehran

Stanford University

PhD Fellowship, Genetics / 2021

Stanford, California, United States of America

Yale University

Postgraduate, Cardiovascular Genetics / 2015

New Haven, Connecticut, United States of America
Experience

Stanford U

Research Expertise (17)
Genomic Medicine
Translational Genomics
Diabetes Prevention
Cardiometabolic Diseases
Single-Cell Genomics
And 12 more
About
## Scientist Genomics I have my major, MSc, and PhD degrees in biology, human, and medical genetics. I have hands-on experience in a variety of molecular biology and genetic techniques and have worked on NGS library preparation, scRNA-seq, and data analysis. As shown in my resume (I can also send my CV if needed), in addition to genomic experiments, I have worked on other omic profiling such as epigenome (DNA methylation), proteomics, and transcriptomics in a variety of samples including human cells and animal tissues. With more than 20 years of work experience, I have worked in hospital, academic, and biotech settings and proactively had to take a strategic thinking and problem-solving approach. Thus, I am adaptable to changing directions and methods, and eager to work in a dynamic, fast-paced research and product development environment. I also have multiple experiences managing multicenter and international collaborations and managing multiple priorities in a cross-functional team. I personally give fundamental value to diversity and building new connections and collaborations, and learning from diverse team members. Continuous learning and teamwork are my core values. There are other examples of my attention to detail, optimizing and troubleshooting techniques and experiments in molecular biology, genomics, and NGS panel design. As an example of my resilience, in a collaboration between CZ Biohub and the Stanford Pediatrics Department, I had to pilot a split-seq and combinatorial barcoding NGS method for newborn lung samples from library preparation up to scRNA-seq analysis. With a strong background in genomics and biology and expertise in the wet lab and data analysis, I could be a valuable asset to the Product Development teams where they need someone to lead and advance genomics research and NGS technology development, outreach, and shaping the future of genomics research, especially in clinical genetics and medical genomics. As I pursue a multidisciplinary collaboration in my scientific rationale, particularly, I am eager to extend my dedication to commercialization and envision the genomics product for financial gain and bringing value to the market. In summary, I have expertise and am eager to continue to design, conduct, and optimize new biological and genomics experiments and elucidate underlying mechanisms. I have more than 20 years of direct work experience in clinical research, both within hospital settings and in functional genomics labs. These roles required me to perform a variety of monitoring tasks depending on the context. This included monitoring lab and patient data, as well as monitoring various types of data such as clinical, molecular, and omics data, including genomics and proteomics. I have experience in developing IVD tests such as NGS panels and Polygenic Risk Scores (PRS) for genetic diseases.

See Full Profile

K. Suzanne Scherf

12 Years Experience
Associate Professor of Psychology & Neuroscience, Penn State University
Education

University of Pittsburgh

PhD, Psychology

Pittsburgh, Pennsylvania, United States of America
Experience

Penn State University

Associate Professor / July, 2017 — Present

Asst Professor / July, 2011 — June, 2017

Research Expertise (36)
developmental cognitive neuroscience
vision
autism
adolescent
Cognitive Neuroscience
And 31 more
About
My core interests lie in understanding how children and adolescents perceive and interpret social signals and how emerging functional specificity of the developing brain supports this process. My approach primarily involves using the face processing system as a model domain. Faces are dynamic stimuli from which we extract many different kinds of information (e.g., gender, age, emotional state, mate potential, social status, trustworthiness, intentions, “person knowledge”). All of these processes must be executed accurately and rapidly for many faces over the course of a single day, making face processing among the most taxing perceptual challenges confronted by people in their day-to-day life. Given that faces are also the pre-eminent social signal, studying developmental changes in the behavioral and brain basis of face processing in typically developing individuals and in those affected by social-emotional disorders may index a core set of developmental changes within the broader social information processing system. I employ converging methodologies, including functional (fMRI) and structural magnetic resonance, and diffusion tensor imaging (DTI) along with detailed behavioral paradigms in both typically developing populations and those with developmental disorders to examine development from early childhood to adulthood.

See Full Profile

Balamurugan Tangiisuran

Boston, Massachusetts, United States of America
14 Years Experience
Associate Professor in Clinical Pharmacy at Universiti Sains Malaysia
Education

Ph.D, Medication safety in Geriatrics / March, 2010

Sussex
Research Expertise (52)
Geriatrics
Pharmacy
Internal Medicine
Psychiatry and Mental health
Clinical Psychology
And 47 more
About
Dr. Bala brings a wealth of knowledge and expertise to his role as an Associate Professor in Clinical Pharmacy at the School of Pharmaceutical Sciences, USM. He has a proven track record of success in his field, having held key leadership positions such as Director at the Malaysian National Poison Centre and Program Chairman (Clinical Pharmacy) at the School of Pharmaceutical Sciences, USM. He holds a Bachelor of Pharmacy from USM and a PhD from Brighton and Sussex Medical School, UK. Additionally, he has been appointed as Visiting Senior Lecturer at King's College London and as a Fellow of the WHO Collaborating Centre for Drug Information at the National Poison Centre. <br> Bala's research focuses on the areas of clinical pharmacy practice and medication safety, as well as geriatric pharmacy. He has published more than 50 peer-reviewed journal articles/abstracts and has been invited as a guest speaker at numerous international and domestic scientific events. He is an experienced internal and external examiner for over 40 PhD and Master thesis and has actively reviewed manuscripts for international academic journals. Bala's teaching activities encompass both undergraduate and postgraduate-level instruction, and he has supervised the research of numerous postgraduate students. He is committed to curriculum development and has implemented innovative and interactive teaching methods to improve student learning outcomes. He has successfully graduated 24 students, including 4 PhDs, 4 MSc, and 16 Master in Clinical Pharmacy. He is dedicated to producing sustainable pharmacy education and closing the knowledge transfer gap for students. If you're interested in Clinical Pharmacy, Geriatric pharmacy, Medication Safety, Research and Education, feel free to connect and exchange ideas.

See Full Profile

Murli Manohar

16 Years Experience
Boyce Thompson Institute, Cornell University
Education

Texas A&M University

Biochemistry, Plant Biology, Biotechnology, Molecular Biology / May, 2012

College Station, Texas, United States of America

Indian Institute of Technology Roorkee

M.S, Biotechnology / May, 2005

Roorkee

B.S, Agriculture / May, 2003

Allahabad
Experience

Ascribe Bioscience Inc.

CTO / February, 2019 — Present

Execute the company's technological roadmap in alignment with business goals and vision. Collaborate with cross-functional teams to drive innovation and enhance crop protection products. Analyze market trends and competitive landscape to identify new technological advancements and product differentiation opportunities. ● Built strong partnerships with Ag-tech firms, investors, academic scholars, and growers. ● Controlled research and development budget of more than $10M to drive innovation into tangible outcomes. ● Developed independent research laboratory and managed R&D, multi-national field tests, and commercialization plans. ● Conducted market research to enhance product offerings and align with customer requirements.

Boyce Thompson Institute for Plant Research

Senior Scientist / September, 2012 — November, 2020

Supported multidisciplinary teams in assessing complex data sets, identifying patterns, and drawing meaningful conclusions. Led design and execution of experiments, ensuring adherence to scientific protocols and research methodologies. Facilitated collaborative research projects and leveraged resources for mutual benefit. ● Recognized as the inventor of several technologies, delivering a foundation for establishing Ascribe Bioscience. ● Uncovered unique processes of plant and animal responses to external stresses. ● Earned promotion to Senior Scientist in 2017 based on excellent performance. ● Expert in the fields of Molecular Biology, Plant Biotechnology, Crop Protection, and Gene Editing. ● Authored revolutionary research publications in Agriculture, Molecular Biology, Biochemistry, Biotechnology, and Natural Chemistry.

Baylor College of Medicine

Graduate Research Assistant/Postdoctoral Associate / May, 2008 — September, 2012

The objective was to study and optimize CAX-mediated biofortification and phytoremediation in plants. My research investigated the physiological functions, structure-function relationship, and inter- and intra-molecular interactions of calcium transporters cation/proton exchangers known as CAX in plants. My research used Saccharomyces cerevisiae (yeast) as the model system to study CAX transporters and established membrane fractionation and enrichment techniques to evaluate the real-time movement of metals between membranes. Moreover, I also characterized new calcium transporters from both plants and animals. Other experience: Hands-on experience in executing potency assays (binding assays, In vitro, In vivo). Hands-on experience in RNAi technology (Designing, cloning, and heterologous expression of siRNA in plants targeting animal mRNA).

Research Expertise (22)
Inter-specific interactions
Chemical signaling
Biopesticides
Plant Science
Ecology, Evolution, Behavior and Systematics
And 17 more
About
Instrumental in leading the development of Ascribe technology from start-up to successful execution. Skilled in identifying and capitalizing on emerging technologies and executing R&D strategic objectives to accelerate the product development process and increase customer centricity across different markets. Excel in overseeing cross-function projects with substantial R&D budgets to transform scientific discoveries into market-ready products. Tech leader and inventor with solid business acumen, holding patents for successful start-up and market-ready products. Expert at developing high-performing teams for commercializing new, differentiated, and disruptive products. Experienced researcher with effective communication and interpersonal skills; known for expanding business by collaborating with industry leaders, academic researchers, and contract research organizations. Passionate about driving innovation and delivering impactful results for business growth and market expansion. As a Ph.D. in Biochemistry, Molecular Biology, and Plant Science, I bring a strong background and expertise in agriculture and biopharmaceutical research. But more than that, I am driven by a deep passion for advancing Agtech, Foodtech, and Biotech solutions. My mission is to harness the power of nature to create sustainable and effective products that can enhance plant and human health.

See Full Profile

Shreeharsha Tarikere

9 Years Experience
Experienced genomic and next gen seq expert in evolutionary and developmental biology studies.
Education

Indian Institute of Science Education Research Pune

PhD, Biology / May, 2015

Pune

Bangalore University

MS, Biotechnology / June, 2006

Bangalore

Government Science College

BS, Microbiology / June, 2004

Bangalore
Experience

Harvard University Department of Organismic and Evolutionary Biology

Post Doctoral Fellow / June, 2015 — Present

Carleton University

Postdoctoral Scientist

Research Expertise (8)
Amphibian
Limbs
Ovary
Wing
Insects
And 3 more
About
I have a decade-long expertise in **next generation sequencing,** **molecular biology, genetics, cell biology** and bioinformatic analysis. I have expertise in designing, optimizing, improvising, and troubleshooting molecular biology experiments through my postdoc at Harvard, Carleton, and PhD from IISER. I have experience of **developing and optimizing new experiments** in next gen seq as I have designed new experiments to do the first silk moth wing ChIP seq, a cell-type specific RNA seq at Harvard and in situs for salamanders at a primarily fossil lab in Carleton University.

See Full Profile

Example Genetics (clinical) projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Genetics (clinical)?

Genetic Disease Research

A pharmaceutical company can collaborate with a Genetics (clinical) expert to conduct research on genetic diseases. This collaboration can lead to the discovery of new treatment options and personalized medicine for patients.

Drug Discovery and Development

By partnering with a Genetics (clinical) researcher, a biotech company can leverage their expertise to identify genetic targets for drug development. This collaboration can accelerate the discovery and development of novel therapeutics.

Agricultural Improvement

An agricultural company can work with a Genetics (clinical) specialist to enhance crop breeding programs. By understanding the genetic basis of desirable traits, companies can develop genetically improved crops with higher yields, disease resistance, and nutritional value.

Biotechnology Advancement

Companies in the biotechnology industry can collaborate with Genetics (clinical) experts to advance gene editing technologies, such as CRISPR. This partnership can lead to breakthroughs in gene therapy, genetic engineering, and precision medicine.

Ethical and Legal Guidance

Companies involved in genetic research and testing can benefit from the expertise of Genetics (clinical) professionals in navigating ethical and legal considerations. They can ensure compliance with regulations, protect patient privacy, and address ethical dilemmas associated with genetic data.